TIAA CREF Investment Management’s Viridian Therapeutics VRDN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $272K | Buy |
6,510
+1,068
| +20% | +$44.6K | ﹤0.01% | 2809 |
|
|
2018
Q4 | $247K | Sell |
5,442
-86
| -2% | -$3.9K | ﹤0.01% | 2826 |
|
|
2018
Q3 | $463K | Sell |
5,528
-613
| -10% | -$51.3K | ﹤0.01% | 2748 |
|
|
2018
Q2 | $590K | Buy |
6,141
+1,905
| +45% | +$183K | ﹤0.01% | 2713 |
|
|
2018
Q1 | $445K | Buy |
4,236
+1,709
| +68% | +$180K | ﹤0.01% | 2790 |
|
|
2017
Q4 | $395K | Buy |
2,527
+107
| +4% | +$16.7K | ﹤0.01% | 2875 |
|
|
2017
Q3 | $332K | Buy |
2,420
+76
| +3% | +$10.4K | ﹤0.01% | 2978 |
|
|
2017
Q2 | $455K | Buy |
+2,344
| New | +$455K | ﹤0.01% | 2903 |
|